Comparative effectiveness of pemafibrate versus bezafibrate on hepatic and vascular endothelial function in patients with coronary artery disease and metabolic dysfunction-associated steatotic liver disease. - Nakamura A; Kagaya Y; Saito H; Kanazawa M; Miura M; Kondo M; Endo H (Frontiers in endocrinology, 2026)